Form 4 for BSX Boston Scientific
Accepted 2024-09-03 00:00:00 ET · period of report 2024-08-30 · accession 0001225208-24-008332 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-09-03 | 2024-08-30 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | G - Gift | $0.00 | +33.0K | 209.3K | +19% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-30 | G | A | 95,041 | $0.00 | 385,523 | I By Trust | — | — | |
| 2 | Common | Common Stock | 2024-08-30 | G | A | 114,237 | $0.00 | 290,482 | I By Trust | — | — | |
| 3 | Common | Common Stock | 2024-08-30 | G | D | 176,245 | $0.00 | 209,278 | I By Trust | — | — |